Last reviewed · How we verify

NCT07484477

Sedentary Behavior Modification, Cardiopulmonary Function & QOL Post Cardiac Surgery Patients.

Not yet recruiting NA Last updated 20 March 2026
What this trial tests

NA trial testing Sedentary Behaviour Modification Protocol in Post-cardiac Surgery Patients in 24 participants. Not yet recruiting.

Timeline
30 March 2026
Primary endpoint
30 July 2026
30 August 2026

Quick facts

Lead sponsorRiphah International University
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeother
Enrollment24
Start date30 March 2026
Primary completion30 July 2026
Estimated completion30 August 2026
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Riphah International University

Who can join

Adults 50 to 80, any sex, with Post-cardiac Surgery Patients. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to investigate randomized controlled trial to evaluate whether reducing sedentary behavior improves recovery in post-cardiac surgery patients. Participants are assigned to either a behavioral intervention that substitutes sitting with light activity or to usual care. Changes in exercise capacity and quality of life are the primary measured outcomes. It is hypothesized that the intervention group will demonstrate superior gains in both physical function and well-being. The results could inform a valuable adjunct to existing cardiac rehabilitation programs.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Riphah International University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07484477.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing